陆朦辰

发布时间：2026-04-14浏览次数：14

  • 1、Discovery of an allosteric 14-3-3 inhibitor for suppressing NRF2-driven cancer via phenotypic screening and chemoproteomic-based target deconvolution,Chem. Sci.,SCI,2025,Jinlong Zhao,Qidong You, Mengchen Lu, Zhengyu Jiang,苏州大学,16 (37), 17248-17260,共通排二
  • 2、Discovery of β-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1−nuclear factor erythroid 2-related factor 2 (Keap1−Nrf2) protein−protein interaction inhibitors for ulcerative colitis management,Eur. J. Med. Chem.,SCI,2025,Ziquan Zhao,Qidong You, Zhengyu Jiang, Mengchen Lu,苏州大学,288, 117384,最后通讯
  • 3、Patenting perspective on Keap1 inhibitors (2019-2024),Expert Opin. Ther. Pat.,SCI,2025,Yongfu Luo,Qidong You, Mengchen Lu,苏州大学,最后通讯
  • 4、Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response,Cell Chem. Biol.,SCI,2023,Mengchen Lu,苏州大学,Qidong You, Zhengyu Jiang,21, S2451-9456,共一排一
  • 5、A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions,Redox Biol. ,SCI,2020,Mengchen Lu,Qidong You, Zhengyu Jiang,34, 101565,共一排一
  • 6、Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown,J Med Chem,SCI,2020,Yuhui Jin, Mengchen Lu,Qidong You, Zhengyu Jiang,63, 4644-4654,共一排二
  • 7、Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions,Eur. J. Med. Chem.,SCI,2020,Mengchen Lu,Qidong You, Zhengyu Jiang,207, 112734,第一作者